In CRS, the activation of T-cells will lead to a significant elevation of the inflammatory cytokines (e.g., IL-6, IL-10, IFN-γ, and GM-CSF) [72,73,74]. The gene discussed is CSF2; the disease is congenital rubella syndrome.